肺癌18基因突变检测(仅供科研)
一次检测与肺癌靶向用药相关的...
BDA技术 针对EGFR基因突变进行高灵敏度检测
A 16-gene NGS panel that detects mutations clinically relevant to lung cancer, down to 0.1% VAF.
Detect AML mutations in 6 genes at 0.1% VAF in <1 day using Nanopore Sequencing
An 8-gene NGS panel that detects mutations clinically relevant to melanoma, down to 0.1% VAF
Targeted qPCR-based assays to identify mutations in 6 genes associated with AML down to 0.1% VAF
Targeted qPCR-based assays to identify EGFR mutations down to 0.1% VAF
Targeted qPCR-based assays to identify BRAF mutations down to 0.1% VAF
An NGS panel for detection of mutation hotspots in 14 genes and copy number variations in 18 genes associated with breast cancer